Cargando…
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time
BACKGROUND: Overdiagnosis in breast cancer screening is a controversial topic. One difficulty in estimation of overdiagnosis is the separation of overdiagnosis from lead time that is the advance in the time of diagnosis of cancers, which confers an artificial increase in incidence when a screening p...
Autores principales: | Duffy, Stephen W, Parmar, Dharmishta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706885/ https://www.ncbi.nlm.nih.gov/pubmed/23680223 http://dx.doi.org/10.1186/bcr3427 |
Ejemplares similares
-
Reply: Estimation of lead-time and overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2009) -
Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening
por: Paci, Eugenio, et al.
Publicado: (2005) -
Estimation of lead time and overdiagnosis in breast cancer screening
por: Gøtzsche, P C, et al.
Publicado: (2009) -
Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer
por: Duffy, Stephen W, et al.
Publicado: (2005) -
Complexities in the estimation of overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2008)